Abstract
ORX750, an oral selective Orexin Receptor 2 agonist, promotes wakefulness and reduces cataplexy in the orexin/ataxin-3 mouse
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have